Cambridge Enterprise

Part of the University of Cambridge, Cambridge Enterprise supports academics, researchers, staff, and students in achieving knowledge transfer and research impact.

We do this by helping innovators, experts and entrepreneurs use commercial avenues to develop their ideas and expertise for the benefit of society, the economy, themselves, and the University.

Liaising with organisations both locally and globally, we offer expert advice and support in commercialisation and social enterprise.

Description of cell lines

Cambridge Enterprise manages the licensing of a variety of cell lines and hybridomas produced at the University of Cambridge. These include but are not limited to:

• KARPAS Cell Lines: Created by Professor Abraham Karpas, these are human Non-Hodgkin's Ki-positive Large Cell Lymphoma cell lines useful in oncology research. They were all established from the peripheral blood of patients with T cell non-Hodgkin lymphoma in the 1980s

• Hybridomas developed by Professor Herman Waldmann with a variety of applications in immunology research.

• CHO cells developed by Dr Mike R Clark.

• HeLa-Mitotrap cell lines developed my Margaret Robinson

Cambridge Enterprise Collection

Explore cell lines from Cambridge Enterprise here.